The world has realised that the next generation medical products will need Asian inputs to become successful. So, they are flocking to set up their research facilities, do a large part of their drug discovery work and conduct clinical trials in a big way to speed up the drug development process.
To appreciate the Asian companies for their commendable performance and achievements during Calendar Year (CY) 2021, and noting that Asia is the new hub for potential growth and innovation, BioSpectrum Asia has set the tone for in the form of BioSpectrum Asia Excellence Awards 2022.
These awards were an extension to observe and highlight the winners in the long battle to tackle the world's emerging health problems and find solutions. Through these awards, BioSpectrum Asia is playing the role of picking tomorrow's winners, nudging today's entrepreneurs to achieve greater glory and honouring yesterday's key players who laid the foundation for success
The nominations were received for the following categories One winner was selected in each of these categories by an international jury panel**.
Click on the category to know more about the selection criteria.
For more details, contact:
Ankit Kankar
Project Lead
ankit.kankar@mmactiv.com
Dr. Manbeena Chawla
Executive Editor
manbeena.chawla@mmactiv.com
Apoorva Mahajan
Key Account Executive
apoorva.mahajan@mmactiv.com
For regional queries, contact:
Saradha Mani
General Manager
saradha.mani@mmactiv.com
Hithaishi C. Bhaskar
Asst. Manager Content Creation and Coordination- APAC Region
hithaishi.cb@mmactiv.com
© 2022 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer
Web Interface Conceived and Powered By : SCI Knowledge Interlinks